CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 22 enrolled
Drug / intervention
Alequeldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02185183
NCT02185183Phase 2Completed
CompareCT.gov

Phase 2 Clinical Trial for Oral Administration of Alequel for Patients With IBD

Hadassah Medical Organization·interventional·Posted Jul 9, 2014·Updated Oct 1, 2014

In Brief

A Phase 2 clinical trial evaluating Alequel for Crohn's Disease. Completed, enrolled 22 participants.

Detailed Summary

Oral administration of Alequel, a mixture of proteins derived from the patient's bowel will be tested in patients with inflammatory bowel disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCrohn's Disease
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 9, 2014
Enrollment StartJan 1, 2008
Primary CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 12.0 years ago

Interventions

Alequeldrug

Alequel